Q11224 (Q11224): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Changed an Item)
Property / financed by
 
Property / financed by: European Union / rank
 
Normal rank
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
 
Normal rank

Revision as of 12:29, 6 February 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
No label defined
Project in Czech Republic financed by DG Regio

    Statements

    country
    Czechia
    0 references
    EU contribution
    24,083,996.56 Czech koruna
    0 references
    963,359.8624 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    1 October 2020
    0 references
    budget
    43,285,400.0 Czech koruna
    0 references
    1,731,416.0 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    1 October 2020
    0 references
    co-financing rate
    55.64 percent
    0 references
    start time
    16 April 2018
    0 references
    expected end time
    30 April 2020
    0 references
    beneficiary name (string)
    AUMED, a.s.
    0 references
    beneficiary
    Q198505
    0 references
    coordinate location

    49°59'56.22"N, 14°25'3.50"E
    0 references
    postal code
    14300
    0 references
    summary
    Předložený projekt řeší problematiku přípravy nové lékové formy specifických imunomodulátorů na bázi transfer faktorů (TF) a metod testování jejich imunobiologického potenciálu a. (Czech)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/16_083/0010301
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q11224&oldid=501975"